| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
|
Yamanaka, Hisashi
|
|
|
7 |
1 |
p. 149-163
|
artikel
|
| 2 |
A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
|
Yamanaka, Hisashi
|
|
|
7 |
1 |
p. 149-163
|
artikel
|
| 3 |
Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
|
DeMizio, Daniel J.
|
|
|
7 |
1 |
p. 19-33
|
artikel
|
| 4 |
Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
|
DeMizio, Daniel J.
|
|
|
7 |
1 |
p. 19-33
|
artikel
|
| 5 |
Cardiovascular Comorbidities in Psoriatic Disease
|
Szentpetery, Agnes
|
|
|
7 |
1 |
p. 5-17
|
artikel
|
| 6 |
Cardiovascular Comorbidities in Psoriatic Disease
|
Szentpetery, Agnes
|
|
|
7 |
1 |
p. 5-17
|
artikel
|
| 7 |
Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study
|
Nyman, Elisabeth
|
|
|
7 |
1 |
p. 201-213
|
artikel
|
| 8 |
Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study
|
Nyman, Elisabeth
|
|
|
7 |
1 |
p. 201-213
|
artikel
|
| 9 |
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
|
Gale, Sara L.
|
|
|
7 |
1 |
p. 89-99
|
artikel
|
| 10 |
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
|
Gale, Sara L.
|
|
|
7 |
1 |
p. 89-99
|
artikel
|
| 11 |
Clinical, Economic, and Humanistic Burden Associated With Delayed Diagnosis of Axial Spondyloarthritis: A Systematic Review
|
Yi, Esther
|
|
|
7 |
1 |
p. 65-87
|
artikel
|
| 12 |
Clinical, Economic, and Humanistic Burden Associated With Delayed Diagnosis of Axial Spondyloarthritis: A Systematic Review
|
Yi, Esther
|
|
|
7 |
1 |
p. 65-87
|
artikel
|
| 13 |
Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
|
van Leeuwen, Kevin D. B.
|
|
|
7 |
1 |
p. 215-216
|
artikel
|
| 14 |
Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
|
van Leeuwen, Kevin D. B.
|
|
|
7 |
1 |
p. 215-216
|
artikel
|
| 15 |
Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis
|
Best, Jennie H.
|
|
|
7 |
1 |
p. 165-171
|
artikel
|
| 16 |
Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis
|
Best, Jennie H.
|
|
|
7 |
1 |
p. 165-171
|
artikel
|
| 17 |
Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
|
Tarrant, Jacqueline M.
|
|
|
7 |
1 |
p. 173-190
|
artikel
|
| 18 |
Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
|
Tarrant, Jacqueline M.
|
|
|
7 |
1 |
p. 173-190
|
artikel
|
| 19 |
Looking Back on 2019 in Rheumatology and What to Expect from 2020
|
Fleischmann, Roy
|
|
|
7 |
1 |
p. 1-3
|
artikel
|
| 20 |
Looking Back on 2019 in Rheumatology and What to Expect from 2020
|
Fleischmann, Roy
|
|
|
7 |
1 |
p. 1-3
|
artikel
|
| 21 |
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
|
Fleischmann, Roy
|
|
|
7 |
1 |
p. 35-64
|
artikel
|
| 22 |
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
|
Fleischmann, Roy
|
|
|
7 |
1 |
p. 35-64
|
artikel
|
| 23 |
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study
|
Zhang, Jing
|
|
|
7 |
1 |
p. 191-200
|
artikel
|
| 24 |
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study
|
Zhang, Jing
|
|
|
7 |
1 |
p. 191-200
|
artikel
|
| 25 |
Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis
|
Spivey, Christina A.
|
|
|
7 |
1 |
p. 133-147
|
artikel
|
| 26 |
Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis
|
Spivey, Christina A.
|
|
|
7 |
1 |
p. 133-147
|
artikel
|
| 27 |
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
|
Emery, Paul
|
|
|
7 |
1 |
p. 121-131
|
artikel
|
| 28 |
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
|
Emery, Paul
|
|
|
7 |
1 |
p. 121-131
|
artikel
|
| 29 |
Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study
|
Schafer, Peter H.
|
|
|
7 |
1 |
p. 101-119
|
artikel
|
| 30 |
Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study
|
Schafer, Peter H.
|
|
|
7 |
1 |
p. 101-119
|
artikel
|
Tijdschrift beschrijving